Safety Considerations and Kidney Monitoring During GLP-1 Treatment While GLP-1 medications demonstrate kidney-protective benefits, existing kidney disease requires careful baseline assessment before starting therapy
Paoletti P, Bellone C, Zhou Q
Papandreou C, Bull M, Zheng Y, et al
Viviscal is significantly less expensive than Nutrafol, but covers fewer of the potential underlying causes and it not fully natural or plant-derived
GoodRx explains that GLP-1 medications, such as semaglutide, can increase the risk of dehydration, especially when followed by gastrointestinal side effects such as vomiting or diarrhea and appetite suppression
Aging Cell 2(2):141143